Institutional access to gene therapy for sickle cell disease – Treatment on a clinical trial or receive a newly approved therapy? Read more about Institutional access to gene therapy for sickle cell disease – Treatment on a clinical trial or receive a newly approved therapy?
Germline genome editing may never have any clinical utility Read more about Germline genome editing may never have any clinical utility
Hippocratic beneficence: The ethical grounding of remedial germline editing Read more about Hippocratic beneficence: The ethical grounding of remedial germline editing
Disclosure as absolution in medicine: Disentangling autonomy from beneficence and justice in artificial intelligence Read more about Disclosure as absolution in medicine: Disentangling autonomy from beneficence and justice in artificial intelligence
Community-based consent model, patient rights, and AI explainability in medicine Read more about Community-based consent model, patient rights, and AI explainability in medicine
Informed agency: Reimagining patient autonomy in the age of machine-assisted healthcare Read more about Informed agency: Reimagining patient autonomy in the age of machine-assisted healthcare
Balancing transparency and trust: Reevaluating AI disclosure in healthcare Read more about Balancing transparency and trust: Reevaluating AI disclosure in healthcare
Beyond disclosure: Rethinking patient consent and AI accountability in healthcare Read more about Beyond disclosure: Rethinking patient consent and AI accountability in healthcare
Mitigating placebo effect in human-AI interaction: Expanding the role(s) of the right to notice and explanation Read more about Mitigating placebo effect in human-AI interaction: Expanding the role(s) of the right to notice and explanation
